store at low temperature
store at -20°C
Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 51,000 |
5 mg | 在庫あり | ¥ 135,000 |
10 mg | 在庫あり | ¥ 216,500 |
25 mg | 在庫あり | ¥ 317,000 |
50 mg | 在庫あり | ¥ 431,500 |
100 mg | 在庫あり | ¥ 581,000 |
説明 | Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP). |
In vitro | Girentuximab is a chimeric version of a mouse monoclonal antibody (mAb) with IgG1 κ light chain and is capable of recognizing the CAIX antigen [1]. |
別名 | cG250, WX-G250, G250 |
分子量 | N/A |
CAS No. | 916138-87-9 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Girentuximab 916138-87-9 Metabolism Carbonic Anhydrase cG250 WX-G250 G250 Inhibitor inhibitor inhibit